Health Care & Life Sciences » Biotechnology | Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
18.13 M
Public Float
17.03 M
Applied Genetic Technologies Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.1
Market Cap
$68.66 M
Shares Outstanding
18.17 M
Public Float
12.38 M

Profile

Address
14193 NW
Alachua Florida 32615
United States
Employees -
Website http://www.agtc.com
Updated 07/08/2019
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W.

Financials

View All

Susan B. Washer
President, Chief Executive Officer & Director
David R. Knop
Executive Director